Acute exacerbation of Hashimoto's thyroiditis in a patient treated with dimethyl fumarate for multiple sclerosis: A case report

INTRODUCTION: Dimethyl fumarate (DMF) has been recently approved for first-line monotherapy of Multiple Sclerosis (MS). Its effects are due to mechanism modulating the immune system and activating antioxidative and neuroprotective pathways. PATIENT CONCERNS: A 59-year-old female patient affected by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciurleo, Rosella, Sessa, Edoardo, Marino, Silvia, D’Aleo, Giangaetano, Bramanti, Placido, Rifici, Carmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831155/
https://www.ncbi.nlm.nih.gov/pubmed/31027063
http://dx.doi.org/10.1097/MD.0000000000015185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831155/
https://www.ncbi.nlm.nih.gov/pubmed/31027063
http://dx.doi.org/10.1097/MD.0000000000015185

Ejemplares similares